(BGS) B&G Foods - Ratings and Ratios
Frozen Vegetables, Canned Beans, Hot Cereals, Spices, Pickles
BGS EPS (Earnings per Share)
BGS Revenue
Description: BGS B&G Foods October 26, 2025
B&G Foods Inc. (NYSE:BGS) is a diversified manufacturer and distributor of shelf-stable and frozen foods, as well as household products, operating primarily in the United States, Canada, and Puerto Rico. The company’s portfolio spans over 100 brands-including iconic names such as Green Giant, Cream of Wheat, and Ortega-and covers categories from canned vegetables and cooking oils to hot cereals, sauces, and specialty snacks. Sales are executed both directly and through a broad network of independent brokers, distributors, and retail partners ranging from supermarket chains to warehouse clubs.
Key operating metrics (FY 2023) show revenue of roughly $2.5 billion, an adjusted EBITDA margin near 9 %, and a net income of $115 million, reflecting modest profitability in a low-growth, price-sensitive segment. The packaged foods sector remains vulnerable to inflation-driven input cost volatility (e.g., commodity prices for corn and canola) and shifting consumer preferences toward private-label and healthier options, which compress margins for legacy brands. B&G’s balance sheet carries $1.2 billion of total debt, giving a leverage ratio of about 3.5× EBITDA, a level that warrants monitoring given potential interest-rate headwinds.
If you want a data-rich, forward-looking assessment of BGS-including consensus earnings forecasts, valuation multiples, and scenario-based risk analysis-consider pulling the company’s profile on ValueRay for a deeper dive.
BGS Stock Overview
| Market Cap in USD | 322m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 2007-05-23 |
BGS Stock Ratings
| Growth Rating | -82.9% |
| Fundamental | 27.7% |
| Dividend Rating | 19.7% |
| Return 12m vs S&P 500 | -55.3% |
| Analyst Rating | 2.43 of 5 |
BGS Dividends
| Dividend Yield 12m | 19.00% |
| Yield on Cost 5y | 4.15% |
| Annual Growth 5y | -20.47% |
| Payout Consistency | 94.0% |
| Payout Ratio | 2.0% |
BGS Growth Ratios
| Growth Correlation 3m | 44.1% |
| Growth Correlation 12m | -66.1% |
| Growth Correlation 5y | -94.2% |
| CAGR 5y | -30.46% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.43 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.78 |
| Sharpe Ratio 12m | -1.46 |
| Alpha | -58.56 |
| Beta | 0.470 |
| Volatility | 51.30% |
| Current Volume | 1808.5k |
| Average Volume 20d | 2022.4k |
| Stop Loss | 3.7 (-7.5%) |
| Signal | -0.39 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-223.9m TTM) > 0 and > 6% of Revenue (6% = 111.7m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.99% (prev 15.33%; Δ 11.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 155.1m > Net Income -223.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (79.9m) change vs 12m ago 0.59% (target <= -2.0% for YES) |
| Gross Margin 21.37% (prev 21.99%; Δ -0.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.23% (prev 59.69%; Δ -0.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.92 (EBITDA TTM -55.5m / Interest Expense TTM 155.4m) >= 6 (WARN >= 3) |
Altman Z'' 1.58
| (A) 0.17 = (Total Current Assets 762.6m - Total Current Liabilities 259.8m) / Total Assets 2.94b |
| (B) 0.17 = Retained Earnings (Balance) 495.6m / Total Assets 2.94b |
| (C) -0.05 = EBIT TTM -143.0m / Avg Total Assets 3.14b |
| (D) 0.21 = Book Value of Equity 501.4m / Total Liabilities 2.44b |
| Total Rating: 1.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 27.72
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 5.41% = 2.71 |
| 3. FCF Margin 6.70% = 1.68 |
| 4. Debt/Equity 4.06 = -2.08 |
| 5. Debt/Ebitda -35.73 = -2.50 |
| 6. ROIC - WACC (= -6.52)% = -8.15 |
| 7. RoE -39.03% = -2.50 |
| 8. Rev. Trend -62.12% = -4.66 |
| 9. EPS Trend -75.36% = -3.77 |
What is the price of BGS shares?
Over the past week, the price has changed by -10.51%, over one month by -9.71%, over three months by +1.84% and over the past year by -45.78%.
Is B&G Foods a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BGS is around 3.27 USD . This means that BGS is currently overvalued and has a potential downside of -18.25%.
Is BGS a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 2
What are the forecasts/targets for the BGS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.1 | 2.5% |
| Analysts Target Price | 4.1 | 2.5% |
| ValueRay Target Price | 3.5 | -13.8% |
BGS Fundamental Data Overview October 31, 2025
P/E Forward = 9.1827
P/S = 0.1727
P/B = 0.718
P/EG = 7.93
Beta = 0.47
Revenue TTM = 1.86b USD
EBIT TTM = -143.0m USD
EBITDA TTM = -55.5m USD
Long Term Debt = 1.98b USD (from longTermDebt, last quarter)
Short Term Debt = 37.8m USD (from shortTermDebt, last quarter)
Debt = 2.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 2.31b USD (321.6m + Debt 2.04b - CCE 54.1m)
Interest Coverage Ratio = -0.92 (Ebit TTM -143.0m / Interest Expense TTM 155.4m)
FCF Yield = 5.41% (FCF TTM 124.8m / Enterprise Value 2.31b)
FCF Margin = 6.70% (FCF TTM 124.8m / Revenue TTM 1.86b)
Net Margin = -12.02% (Net Income TTM -223.9m / Revenue TTM 1.86b)
Gross Margin = 21.37% ((Revenue TTM 1.86b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Gross Margin QoQ = 20.49% (prev 21.18%)
Tobins Q-Ratio = 0.78 (Enterprise Value 2.31b / Total Assets 2.94b)
Interest Expense / Debt = 1.76% (Interest Expense 35.8m / Debt 2.04b)
Taxrate = 22.14% (-2.78m / -12.6m)
NOPAT = -111.3m (EBIT -143.0m * (1 - 22.14%)) [loss with tax shield]
Current Ratio = 2.93 (Total Current Assets 762.6m / Total Current Liabilities 259.8m)
Debt / Equity = 4.06 (Debt 2.04b / totalStockholderEquity, last quarter 501.4m)
Debt / EBITDA = -35.73 (negative EBITDA) (Net Debt 1.98b / EBITDA -55.5m)
Debt / FCF = 15.89 (Net Debt 1.98b / FCF TTM 124.8m)
Total Stockholder Equity = 573.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.62% (Net Income -223.9m / Total Assets 2.94b)
RoE = -39.03% (Net Income TTM -223.9m / Total Stockholder Equity 573.7m)
RoCE = -5.59% (EBIT -143.0m / Capital Employed (Equity 573.7m + L.T.Debt 1.98b))
RoIC = -4.29% (negative operating profit) (NOPAT -111.3m / Invested Capital 2.60b)
WACC = 2.24% (E(321.6m)/V(2.36b) * Re(7.75%) + D(2.04b)/V(2.36b) * Rd(1.76%) * (1-Tc(0.22)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.78%
[DCF Debug] Terminal Value 71.32% ; FCFE base≈127.9m ; Y1≈87.2m ; Y5≈43.1m
Fair Price DCF = 10.45 (DCF Value 836.1m / Shares Outstanding 80.0m; 5y FCF grow -37.19% → 3.0% )
EPS Correlation: -75.36 | EPS CAGR: -69.09% | SUE: -2.80 | # QB: 0
Revenue Correlation: -62.12 | Revenue CAGR: -7.66% | SUE: -0.28 | # QB: 0
Additional Sources for BGS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle